[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

GR3027668T3 - Immunosuppressive compositions - Google Patents

Immunosuppressive compositions

Info

Publication number
GR3027668T3
GR3027668T3 GR980401847T GR980401847T GR3027668T3 GR 3027668 T3 GR3027668 T3 GR 3027668T3 GR 980401847 T GR980401847 T GR 980401847T GR 980401847 T GR980401847 T GR 980401847T GR 3027668 T3 GR3027668 T3 GR 3027668T3
Authority
GR
Greece
Prior art keywords
compound
suppressor cell
immunosuppressive
cell inducing
inducing
Prior art date
Application number
GR980401847T
Other languages
English (en)
Inventor
Alison Mary Badger
Original Assignee
Anormed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anormed Inc filed Critical Anormed Inc
Publication of GR3027668T3 publication Critical patent/GR3027668T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Transplantation (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GR980401847T 1990-08-10 1998-08-19 Immunosuppressive compositions GR3027668T3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US56582690A 1990-08-10 1990-08-10
US62245290A 1990-12-05 1990-12-05
PCT/US1991/005619 WO1992002229A1 (en) 1990-08-10 1991-08-07 Immunosuppressive compositions

Publications (1)

Publication Number Publication Date
GR3027668T3 true GR3027668T3 (en) 1998-11-30

Family

ID=27073977

Family Applications (1)

Application Number Title Priority Date Filing Date
GR980401847T GR3027668T3 (en) 1990-08-10 1998-08-19 Immunosuppressive compositions

Country Status (12)

Country Link
EP (1) EP0542860B1 (el)
JP (1) JP2675194B2 (el)
KR (1) KR100215167B1 (el)
AT (1) ATE166228T1 (el)
AU (1) AU658577B2 (el)
CA (1) CA2088492A1 (el)
DE (1) DE69129459T2 (el)
DK (1) DK0542860T3 (el)
ES (1) ES2118087T3 (el)
GR (1) GR3027668T3 (el)
HK (1) HK1011503A1 (el)
WO (1) WO1992002229A1 (el)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5286731A (en) * 1991-09-17 1994-02-15 American Home Products Corporation Method of treating immunoinflammatory bowel disease
US5286730A (en) * 1991-09-17 1994-02-15 American Home Products Corporation Method of treating immunoinflammatory disease
GB9217121D0 (en) * 1992-08-13 1992-09-23 Smithkline Beecham Corp Methods
GB9217116D0 (en) * 1992-08-13 1992-09-23 Smithkline Beecham Corp Methods
EP0605161A3 (en) * 1992-12-29 1994-10-05 American Home Prod Lowering the rheumatoid factor level.
US5455045A (en) * 1993-05-13 1995-10-03 Syntex (U.S.A.) Inc. High dose formulations
CH686761A5 (de) 1993-05-27 1996-06-28 Sandoz Ag Galenische Formulierungen.
EP0721335B1 (en) * 1993-10-01 2005-08-31 Roche Palo Alto LLC Mycophenolate mofetil high dose oral suspensions
US5561138A (en) * 1994-12-13 1996-10-01 American Home Products Corporation Method of treating anemia
BR9601909A (pt) * 1995-07-13 1999-10-13 Smithkline Beecham Corp N,n-dietil-8,8-dipropil-2-azaspiro(4,5)decano-2-propan amina dimaleato
BE1009856A5 (fr) 1995-07-14 1997-10-07 Sandoz Sa Composition pharmaceutique sous la forme d'une dispersion solide comprenant un macrolide et un vehicule.
US5843936A (en) * 1996-06-28 1998-12-01 Bernstein; Lawrence R. Topical administration of azaspiranes to prevent or treat skin conditions associated with hyperproliferation of keratinocytes
DE19728436A1 (de) * 1997-07-03 1999-01-07 Niels Franke Niedrigdosierte 15-Desoxyspergualin-Präparate
WO2006115509A2 (en) 2004-06-24 2006-11-02 Novartis Vaccines And Diagnostics Inc. Small molecule immunopotentiators and assays for their detection

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963557A (en) * 1987-09-28 1990-10-16 Smithkline Beecham Corporation Immunomodulatory azaspiranes

Also Published As

Publication number Publication date
AU8412091A (en) 1992-03-02
EP0542860A4 (en) 1993-08-04
EP0542860B1 (en) 1998-05-20
CA2088492A1 (en) 1992-02-11
DE69129459T2 (de) 1998-10-15
WO1992002229A1 (en) 1992-02-20
HK1011503A1 (en) 1999-07-09
DE69129459D1 (de) 1998-06-25
EP0542860A1 (en) 1993-05-26
ES2118087T3 (es) 1998-09-16
AU658577B2 (en) 1995-04-27
KR100215167B1 (ko) 1999-08-16
JP2675194B2 (ja) 1997-11-12
JPH06500321A (ja) 1994-01-13
ATE166228T1 (de) 1998-06-15
DK0542860T3 (da) 1999-02-15

Similar Documents

Publication Publication Date Title
HK1011503A1 (en) Immunosuppressive compositions
ATE189400T1 (de) Knochenwachstumsfördernde zusammensetzung
HUT58745A (en) Process for produicng rapamycin derivatives and pharmaceutical compositions containing them as active components
HU9302762D0 (en) N-sulfonyl-2-oxoindole derivatives being effective on vasopressin and/or oxitocin receptors
GB9410987D0 (en) High dosage pharmaceutical compositions
CA2034484A1 (en) Radioimmunotherapy using .alpha.-particles emission
ZA967880B (en) Compositions and methods for inhibition of the patho-physiologic actions in mammals in tumor necrosis facto-alpha
DE69434121D1 (de) Pharmazeutische zusammensetzung zur immunstimulierenden therapie
PT951473E (pt) Novos derivados da ciclosporina sua preparacao e composicoes farmaceuticas que os contem
ES2098672T3 (es) Composiciones farmaceuticas estabilizadas que contienen derivados de vitaminas d2 y d3.
DE59406938D1 (de) Pharmazeutische zubereitungen mit einem wirkstoff, der modifizierte amidingruppen enthält
PL294148A1 (el)
KR860000867A (ko) 급성 방사선 증후군 발현억제 및 패혈증 발현억제의 방법 및 그 조성물
IL88971A0 (en) Disubstituted pyridines,their preparation and pharmaceutical compositions containing them
GEP20084346B (en) Protein kinase c inhibitors
UA29415C2 (uk) Засіб для попередження блювання і фармацевтичний препарат
IL105475A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING 1a, 24(R) - DIHYDROXY-22(E)-DEHYDRO- VITAMIN D3 FOR TREATING OSTEOPOROSIS
CA2361081A1 (en) Chaperonin 10 and .beta.-interferon therapy of multiple sclerosis
ZA924107B (en) Immunomodulatory azaspiranes
KR910002792A (ko) 1-치환된-2-(3-아미노-1-프로피닐)피롤리딘 유도체, 그에 의한 중추 콜린성 기능 장해 치료 방법 및 그로구성되는 제약학적 조성물
IL85388A0 (en) Pharmaceutical compositions containing oxoquinazoline derivatives for the treatment of hyperuricaemia
NZ220800A (en) Tetrahydrobenzothiazoles and pharmaceutical compositions
LT96094A (en) The active ingredient of pharmaceutical composition for treating constipation
GB9006023D0 (en) Synergistic compositions
PL307238A1 (en) Derivatives of ng-monomethyl-l-arginin hydrochloride and their application in treating septic shocks